Net loss of Genomic Valley Biotech reported to Rs 0.04 crore in the quarter ended March 2024 as against net profit of Rs 0.98 crore during the previous quarter ended March 2023. There were no Sales reported in the quarter ended March 2024 as against Rs 1.00 crore during the previous quarter ended March 2023.For the full year,net profit declined 96.92% to Rs 0.02 crore in the year ended March 2024 as against Rs 0.65 crore during the previous year ended March 2023. Sales declined 93.75% to Rs 0.17 crore in the year ended March 2024 as against Rs 2.72 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales01.00 -100 0.172.72 -94 OPM %093.00 -11.7632.35 - PBDT-0.040.94 PL 0.020.92 -98 PBT-0.040.95 PL 0.020.91 -98 NP-0.040.98 PL 0.020.65 -97 Powered by Capital Market - Live News

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 9 May 2024.Powered by Capital Market - Live News

Net profit of Genomic Valley Biotech reported to Rs 0.02 crore in the quarter ended December 2023 as against net loss of Rs 0.85 crore during the previous quarter ended December 2022. Sales declined 94.03% to Rs 0.04 crore in the quarter ended December 2023 as against Rs 0.67 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.040.67 -94 OPM %50.005.97 - PBDT0.020.05 -60 PBT0.020.05 -60 NP0.02-0.85 LP Powered by Capital Market - Live News

Genomic Valley Biotech has revised the meeting of the Board of Directors which was scheduled to be held on 10 February 2024. The meeting will now be held on 14 February 2024.Powered by Capital Market - Live News

Genomic Valley Biotech has revised the meeting of the Board of Directors which was scheduled to be held on 10 February 2024. The meeting will now be held on 14 February 2024.Powered by Capital Market - Live News